| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 17.818 | 17.636 | 17.338 | 19.426 | 20.230 | 19.847 | 19.406 | 22.062 | 25.715 | 26.778 |
| Total Income - EUR | 17.818 | 17.637 | 17.824 | 19.902 | 20.230 | 20.351 | 19.477 | 22.062 | 25.715 | 26.778 |
| Total Expenses - EUR | 6.732 | 8.238 | 8.283 | 8.838 | 9.111 | 9.853 | 8.709 | 9.692 | 11.464 | 12.124 |
| Gross Profit/Loss - EUR | 11.086 | 9.399 | 9.541 | 11.064 | 11.119 | 10.497 | 10.768 | 12.370 | 14.251 | 14.654 |
| Net Profit/Loss - EUR | 9.308 | 7.876 | 8.014 | 10.865 | 10.917 | 10.309 | 10.577 | 12.154 | 12.016 | 12.356 |
| Employees | 1 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - United Ropharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.270 | 628 | 0 | 714 | 306 | 29 | 0 | 0 | 0 | 0 |
| Current Assets | 10.531 | 9.655 | 9.944 | 11.954 | 12.717 | 14.238 | 23.942 | 16.622 | 16.831 | 26.498 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.008 | 1.817 | 1.806 | 2.051 | 2.012 | 1.973 | 1.924 | 11.143 | 2.670 | 2.655 |
| Cash | 8.523 | 7.838 | 8.139 | 9.903 | 10.705 | 12.265 | 22.017 | 5.479 | 14.161 | 23.843 |
| Shareholders Funds | 9.362 | 7.929 | 8.067 | 10.917 | 10.967 | 10.359 | 10.625 | 12.203 | 12.065 | 12.404 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.543 | 2.453 | 1.877 | 1.847 | 2.155 | 3.969 | 13.429 | 4.563 | 4.963 | 14.274 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - United Ropharma Srl